Get started

Class action, filed Oct 21, 2026

Solgar VM-75 vitamin B6 lawsuit

A proposed class action filed on October 21, 2026 in federal court in New Jersey says Nestle, which has owned the Solgar brand since August 9, 2021, sold Solgar Formula VM-75 with 75 mg of vitamin B6 per daily dose, about 44 times the U.S. Recommended Dietary Allowance, without warning of a risk of peripheral neuropathy. For everyone who bought VM-75, it seeks a refund or price difference, a label warning or reformulation, and other damages. No class has been certified and Nestle has not answered as of November 16, 2026.

Filed
Oct 21, 2026

Key facts

Potential payout
No amount set; the complaint seeks up to the full purchase price or the price difference
Status
Complaint filed; no class certified
Case number
2:26-cv-13703
Court
U.S. District Court for the District of New Jersey
Class counsel
Seeger Weiss LLP; Lieff Cabraser Heimann & Bernstein, LLP (proposed, for the plaintiffs)
Who qualifies
US residents who bought Solgar Formula VM-75 (proposed class); a California subclass
How to join
No sign up needed to be in a proposed class

What the lawsuit says

The case is Higgins v. Nestle Health Science US Holdings, Inc., filed on October 21, 2026 in the U.S. District Court for the District of New Jersey against Nestle Health Science US Holdings, Inc. and Nestle S.A. The complaint says Solgar Formula VM-75 was first made by the Solgar Vitamin and Herb Co. in 1975, and that Nestle acquired the Solgar brand on August 9, 2021 and took over its formula, labeling and sales.

The complaint says each daily dose of VM-75 contains 75 mg of vitamin B6, roughly 44 times the U.S. Recommended Dietary Allowance, and that medical literature going back to at least 1983 links long term use of high dose B6 to peripheral neuropathy, a nerve condition. It says regulators in the U.K., the E.U., the Netherlands and Norway set tolerable upper intake levels for B6 between 10 mg and 25 mg a day, and that Canada and Australia require a warning on supplements with more than 10 mg of B6 per daily dose.

According to the complaint, VM-75's label carries a California Proposition 65 warning about lead but no warning about B6, and Nestle markets it as a "premium multivitamin" for "overall health and well-being." It says buyers would not have bought VM-75, or would have paid less, had they known. One plaintiff also brings his own personal injury claims, which are separate from the class claims. These are allegations; Nestle has not answered as of November 16, 2026.

Who qualifies

The complaint proposes a nationwide class of "All residents of the United States and its territories who purchased Solgar Formula VM-75." In the alternative, it proposes a California subclass of "All residents of California who purchased Solgar Formula VM-75."

The class claims are about money spent on the product. No injury or diagnosis is needed to be in the proposed class. Neither the class nor the subclass has been certified.

How much you could get and why

The complaint does not name a dollar figure. For the class, it asks for economic damages measured in one of three ways: the full amount people spent on VM-75, the difference between what VM-75 was worth with no warning and what it would have been worth with one, or the difference between its actual value and the price paid. It also asks for exemplary, statutory and punitive damages, disgorgement or restitution, a declaration that the B6 dose is a health risk Nestle had to disclose, and an order to reformulate the product or add a front of pack warning.

The class claims are breach of express and implied warranty, the New Jersey Consumer Fraud Act, fraud by concealment and unjust enrichment, plus, for the California subclass, the Consumers Legal Remedies Act, the Song-Beverly Consumer Warranty Act and the Unfair Competition Law. Any money would come only if the case settles or the plaintiffs win. Receipts or online order records for VM-75 are worth keeping.

How to join

No sign up is needed to be in a proposed class. If the court certifies a class or approves a settlement, class members are sent notice with instructions. Use the button on this page to get alerts from Claim if this case settles.

Timeline

  • 1975: Solgar Vitamin and Herb Co. introduced Solgar VM-75, according to the complaint.
  • August 9, 2021: Nestle acquired the Solgar brand, according to the complaint.
  • June 22, 2026: lawyers for one plaintiff sent Nestle Health Science a letter asking it to reimburse every VM-75 buyer, according to the complaint.
  • October 20, 2026: lawyers for the California plaintiff sent notice letters under California consumer law, according to the complaint.
  • October 21, 2026: Higgins v. Nestle Health Science US Holdings, Inc. was filed in the District of New Jersey, No. 2:26-cv-13703.
  • November 16, 2026: no class certified and no answer from Nestle on the record.

What happens next

Nestle will respond to the complaint, often with a motion to dismiss. The complaint says the California plaintiff will amend it to ask for damages under the Consumers Legal Remedies Act if Nestle does not correct the problem within 30 days of the October 20, 2026 notice. If the case continues, the plaintiffs may ask the court to certify the class. No settlement has been reported as of November 16, 2026.

Frequently asked questions

Is the Solgar VM-75 lawsuit real?

Yes. Higgins v. Nestle Health Science US Holdings, Inc., No. 2:26-cv-13703, was filed on October 21, 2026 in the U.S. District Court for the District of New Jersey.

Do I need proof?

Not now, because there is no settlement or claim form. Receipts or order history showing Solgar VM-75 purchases could help if a settlement opens.

How much could I get?

No amount has been set. The complaint asks for up to the full purchase price, or the price difference, for each buyer, but any payment depends on a settlement or a win at trial.

Is there a deadline?

No. There is no settlement and no claim deadline as of November 16, 2026.

Does it cost anything?

No. Being in a proposed class costs nothing. Class action lawyers are usually paid from any recovery with court approval.

Do I need a lawyer?

No. The plaintiffs' lawyers at Seeger Weiss and Lieff Cabraser Heimann and Bernstein are asking to represent the whole class.

Claim finds settlements you qualify for and helps you file.

Get alerts if this case settles

Related pages